protéine (2) famille (2) survie (2) Treatment (2) Peptidylprolyl isomerase (2) Survival (2) Serum (2) Patients (2) Mice (2) Human beings (2) Ligands (2) Fusion (2) Families (2) Cells (2) Properties (2) Patients (2) Family (2) administration (1) poids (1) acte législatif (1) spectacle (1) pharmacocinétique (1) persistance (1) exposition (1) dose (1) adulte (1) Development (1) Inhibitors (1) Forms (1) Year (1)